UCL is one of Europe's largest and most productive centres of biomedical research. We were the top-rated university in the UK for research strength in the most recent Research Excellence Framework. Our scientists have an international reputation for leading basic, translational and clinical cancer research and the Cancer Institute is uniquely positioned to leverage the multidisciplinary nature of UCL by engaging a range of disciplines to transform cancer research.
- Cancer Biology - Dept. Head: Professor Simona Parrinello
- Clinical Trials - Dept. Head: Professor Jonathan Ledermann
- Haematology - Dept. Head: Professor Kwee Yong
- Oncology - Dept. Head: Professor Daniel Hochhauser
- Pathology - Dept. Head: Professor Adrienne Flanagan
Centres and networks
- Bill Lyons Informatics Centre
- Cancer Immunotherapy Accelerator (CITA)
- Cancer Research UK - UCL Centre
- Cancer Research UK City of London Centre
- Cancer Research UK Brain Tumour Centre of Excellence
- Cancer Research UK Lung Cancer Centre of Excellence
- Comprehensive Cancer Imaging Centre
- Experimental Cancer Medicine Centre
- The Medical Research Council Laboratory for Molecular Cell Biology (MRC LMCB)
- NIHR Blood and Transplant Research Unit - Stem Cells and Immunotherapies
UCL CAR T cell Programme
The UCL CAR T cell programme is based in the Cancer Institute and coordinates developing and testing of new engineered T cell therapies.
Cancer Institute Translational Technology Platforms
The Cancer Institute Translational Technology Platforms provide scientific infrastructure for cutting edge basic, translational and clinical cancer services to support cancer researchers at UCL.